logo
How women have been impacted by Musk-led federal layoffs

How women have been impacted by Musk-led federal layoffs

Yahoo08-05-2025
The federal government is the largest employer in the country — and has historically been a stable one. But then tech billionaire Elon Musk mounted a push to slash agency jobs across the executive branch, driving nearly half of all layoffs across in the United States so far in 2025, according to one jobs report from this month.
But women and people of color are among those most affected by cuts to certain agencies, according to a new analysis from the National Women's Law Center (NWLC). The layoffs and buyouts have shaken the government employee base, which has more built-in protections and benefits than many positions in the private sector.
'The elimination of all these federal jobs passes these female workers into a market that does discriminate on the basis of sex,' said Jacqueline Simon, policy director for the American Federation of Government Employees, a union that represents over 750,000 federal workers.
On his first day in office, President Donald Trump signed an executive order terminating any federal programs related to diversity, equity and inclusion (DEI) — a sweeping and vague mandate that put even marginally related initiatives on the chopping block. Coupled with that was Musk's so-called Department of Government Efficiency (DOGE), which had unprecedented and far-reaching authority to dictate agency reductions and closures.
Women made up the majority of workers in departments — including Veterans Affairs, Education, Health and Human Services, Treasury, and Housing and Urban Development — targeted for these larger-scale layoffs. Women also make up the majority of employees at the U.S. Agency for International Development (USAID), the Consumer Financial Protection Bureau and Voice of America, which are among other agencies that have been or are expected to be gutted or shuttered altogether.
This has pulled out the 'explicit' career ladders on which women federal employees could rely, according to Simon.
'You can't find yourself in a situation that says, 'You're doing really great work, but sorry, we don't have room for any promotions,'' Simon said. 'Promotions were sort of built in — it was and is a positive attribute of federal employment for any group that experiences discrimination when it comes to career advancement.'
Media organizations and watchdog groups don't have exact numbers on the roughly 280,000 federal employees who have been impacted in some way by the second Trump-era cuts and buyouts. Current data does not suggest that women have been disproportionately or specifically targeted for mass terminations.
But an overt lack of transparency means experts cannot meaningfully dissect the cuts and buyouts. The White House recently removed current and historic diversity data from public government websites, further obscuring the effects of mass layoffs. Numbers like those in the NWLC report are so far the closest to approximating the populations that have been most affected by Musk's reduction efforts.
However, the series of layoffs illuminates the diversity in the federal government's 2.3 million workers, 47 percent of whom were women as of September 2024. While the stereotype of an older White man in government might be true for leadership and supervisory positions, she said the report shows how many women and people of color have found a path to the middle class through stable government jobs, which carried predictable schedules, raises and union representation. They are also supposed to be protected from arbitrary firings.
'The federal government creates such great opportunities and has such quality jobs that we don't always see in the private industry,' said Sarah Javaid, the report's author. 'It is a huge attraction to people, and it is far more diverse than we initially thought. It's so clear why people come to these jobs.'
'All those things are rare in the private sector, and now they're being obliterated,' said Liz Morris, co-director of the Center for WorkLife Law.
The California-based advocacy organization focuses on gender and racial equity, and opened a hotline for laid-off workers in April to help connect them with legal help. Morris said that before this year's layoffs, they had never received so many calls from federal workers.
Outside of layoffs, she said caregivers and pregnant workers have endured the deepest impact from the changes to federal employee standards, including orders earlier this year to return to work in-person and a lack of reasonable accommodations. Attempts to address these concerns can go unanswered when human resources departments within these same agencies have also been gutted, Morris added.
'People who are expecting a baby … a time when a stable income is absolutely critical — people are being terminated, having their termination reversed by a court order, then they're being terminated again — all the while they have a baby on the way,' she said. She added that other factors like economic strain, losing health insurance or job searching while pregnant compound the fear many workers feel right now.
She said she has even heard from employees who have returned from parental leave only to be fired and asked to pay back the leave they just took.
'In the past, the federal government was an excellent employer,' Morris said. 'Any employer can make missteps, but generally, federal employees could count on civil service protections… That security has been shattered.'
The post How women have been impacted by Musk-led federal layoffs appeared first on The 19th.
News that represents you, in your inbox every weekday. Subscribe to our free, daily newsletter.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Putin stalls. Trump changes his mind. Ukraine targets Moscow. Latest on the war.
Putin stalls. Trump changes his mind. Ukraine targets Moscow. Latest on the war.

USA Today

time15 minutes ago

  • USA Today

Putin stalls. Trump changes his mind. Ukraine targets Moscow. Latest on the war.

Russian President Vladimir Putin is stalling over a ceasefire. The White House has changed its mind about sending weapons to Ukraine. A major Ukrainian drone attack on Russia sowed chaos at airports serving Moscow. Russia's summer offensive in Ukraine has seen Moscow make its largest territorial gains in Ukraine since the start of the year, according to the Ukrainian open-source DeepState website and estimates by the Institute for the Study of War, a think tank in Washington, D.C., that specializes in military affairs and warfare. In the past month, Russian military units concentrated in Ukraine's Sumy region, which borders Russia in the northeast, the eastern cities of Pokrovsk and Kostyantynivka, and Zaporizhzhia in the south, have gained about 200 square miles, according to data from the war study institute. That's an area a little larger than the size of Atlanta. Does that mean Russia is prevailing? Not really. It's not that simple. Here's the latest on Russia's war in Ukraine. Why is Russia gaining ground in Ukraine? Ukraine has liberated about 7% of the territory Russia occupied before and after Moscow's full-scale invasion in February 2022, according to Ukrainian estimates and DeepState. That leaves about 19% still in Russian hands. Moscow still controls Crimea, which it annexed in 2014, and about two-thirds of Ukraine's Donetsk region, a vast and heavily industrialized region which remains the center of the ground war. Russia has long had the upper hand in the war in terms of military manpower, but analysts say Moscow has suffered more casualties, and its loss of equipment − vehicles, artillery, tanks − also has been at a higher rate than Ukraine's. Though Russia has been advancing in recent months, those gains have been relatively slow and small, amounting to less than 0.1% of Ukraine's territory in July, according to a manual calculation. Still, one reason Russia may have been able to make progress, according to the war study institute, is that Russia has substantially increased its use of drone attacks, and missiles and shells, on Ukraine. These grew at an average monthly rate of 31% in June and July. Russia has been using drones to pin down Ukrainian troops. No, then yes, to more American weapons for Ukraine. Why? President Donald Trump began his second term promising to end the war in Ukraine in his first 24 hours in office. He quickly halted the flow of military aid to Kyiv and temporarily stopped sharing some intelligence. He also cast blame on Ukraine for the war, giving President Volodymyr Zelenskyy a public dressing down in the Oval Office when he tried to push back on that assertion and counter Trump by saying Putin was not a reliable negotiator. Since then, the leaders have revised their stances and welcomed more nuance in their discussions. The war is still raging. Trump has appeared to change his tune on Ukraine and Putin as the Russian leader has pushed forward with drone and missile attacks on Ukrainian cities and repeatedly rebuffed Trump's attempts to broker a ceasefire. In early July, Trump said he would resume shipping arms to Ukraine. He also announced a new arrangement with NATO that will see the military alliance transfer advanced U.S.-made air defense systems to Kyiv. He also altered his attitude about the Russian leader. "He's very nice to us all the time," Trump said July 9. "But it turns out to be meaningless." What about the diplomacy? Two rounds of Trump-brokered ceasefire talks between Ukraine and Russia have come to nothing. As the relationship between Putin and Trump has soured, a broad coalition of U.S. lawmakers has lined up ready to place new aggressive sanctions on Russia. Trump also has threatened "severe" economic penalties on Moscow if it does not commit to a ceasefire by early September. The Kremlin has dismissed this as "bluster." The Russian government has suggested that Trump and Putin could meet in Beijing in September when Russia's leader is there for the 80th anniversary of the end of World War II. Moscow said it had not heard whether Trump plans to attend. The White House has not commented. But there's little doubt Moscow, for now, is on the back foot geopolitically, and perhaps even militarily. Zelenskyy and French Foreign Minister Jean-Noel Barrot announced in Kyiv a series of manufacturing deals with French companies on July 21 that will launch drone production in Ukraine. Overnight, Russia launched its latest barrage of drones and missiles at Kyiv. But Ukraine is also fighting back in ways increasingly difficult for Moscow to ignore. Videos published by Russian media showed people sleeping on the floor of Sheremetyevo, Russia's busiest airport, amid long lines and canceled flights after Ukraine bombarded it with drones.

DOJ drops challenge to Tennessee's gender care ban for minors
DOJ drops challenge to Tennessee's gender care ban for minors

UPI

time16 minutes ago

  • UPI

DOJ drops challenge to Tennessee's gender care ban for minors

Participants walk up Market Street in the 55th annual San Francisco Pride Parade in San Francisco on Sunday, June 29, 2025. On Monday, the Justice Department dropped a lawsuit challenging Tennessee's ban on minors receiving gender-affirming medical care. File Photo by Terry Schmitt/UPI | License Photo July 22 (UPI) -- The Justice Department has dismissed a Biden-era lawsuit challenging Tennessee's law banning gender-affirming care for minors, as the Trump administration continues to attack the rights and medical care of transgender Americans. Attorney General Pam Bondi announced that her department's Civil Rights Division dismissed the lawsuit in a statement Monday that said the Justice Department "does not believe challenging Tennessee's law serves the public interest." Gender-affirming care includes a range of therapies, including psychological, behavioral and medical interventions, with surgeries for minors being exceedingly rare. According to a recent Harvard study, cisgender minors and adults were far more likely to undergo analogous gender-affirming surgeries than their transgender counterparts. Every major American medical association supports gender-affirming care for both adults and minors, including the American Academy of Pediatrics and the American Medical Association, the largest national medical association. Despite the support of the medical community and evidence of its efficacy, gender-affirming care and this marginalized community continue to be targeted by conservatives and Republicans with legislation. Tennessee enacted Senate Bill 1 in March 2023 to prohibit healthcare professionals from prescribing puberty blockers or hormones to minors to treat gender dysphoria, which attracted a lawsuit from the Justice Department under President Joe Biden, arguing the law violated the 14th Amendment's Equal Protection Clause, as all other minors continued to have access to the same procedures and treatments. The conservative movement targeting the healthcare of transgender minors has since gained a supporter in the White House with the re-election of President Donald Trump. Since returning to power, Trump has implemented an agenda targeting transgender Americans, including directing the federal government to recognize only two sexes determined at "conception," restricting gender-affirming care for youth and banning transgender Americans from the military. Last month, the conservative-leaning Supreme Court ruled 6-3 against the Biden administration's complaint to overturn the Tennessee law. The ruling fell along ideological lines, with the conservative justices voting for the law to stand. The liberal justices dissented. "By retreating from meaningful review exactly where it matters most, the Court abandons transgender children and their families to political whims," Justice Sonia Sotomayor said in her dissent. "Tennessee's ban applies no matter what a minor's parents and doctors think, with no regard for the severity of the minor's mental health conditions or the extent to which treatment is medically necessary for an individual child." Bondi on Monday said the Supreme Court made "the right decision." Assistant Attorney General Harmeet Dhillon of the Justice Department's Civil Rights Division said that by dismissing the lawsuit, they "undid one of the injustices the Biden administration inflicted upon the country."

AstraZeneca to invest $50 billion in the U.S. as pharma tariffs weigh
AstraZeneca to invest $50 billion in the U.S. as pharma tariffs weigh

CNBC

time16 minutes ago

  • CNBC

AstraZeneca to invest $50 billion in the U.S. as pharma tariffs weigh

AstraZeneca on Monday said it plans to invest $50 billion in bolstering its U.S. manufacturing and research capabilities by 2030, becoming the latest pharmaceutical firm to ramp up its stateside spending in the wake of U.S. trade tariffs. The Anglo-Swedish biotech company, which is headquartered in Cambridge, England, said the "cornerstone" of the commitment would be a new multi-billion dollar facility to produce its weight management and metabolic portfolio, including its oral GLP-1 obesity pill. The facility, planned for the Commonwealth of Virginia, is set to be AstraZeneca's largest single manufacturing investment in the world and will "leverage AI, automation and data analytics to optimize production," the company said. The latest funding will also expand research and development and cell therapy manufacturing in Maryland, Massachusetts, California, Indiana and Texas, and create "tens of thousands of jobs," AstraZeneca added. CEO Pascal Soriot said the commitment underpins the firm's "belief in America's innovation in biopharmaceuticals" and would support its ambition to reach $80 billion in annual revenue by 2030, half of which is expected to come from the U.S. AstraZeneca, which made international headlines by developing one of the key Covid-19 vaccines, has long been prioritizing the U.S. market. The United States accounted for over 40% of the company's annual revenues in 2024. In November, shortly after the U.S. presidential election, AstraZeneca announced a $3.5 billion U.S. investment. Earlier this month, The Times reported that the firm may move its listing from London to the U.S., in what analysts said would be a major blow to the U.K.'s public markets. AstraZeneca is the most valuable business listed on London's FTSE 100. The company declined to comment on the Times report. AstraZeneca's funding announcement follows similar moves by global pharmaceutical firms — including Novartis, Sanofi and Roche and U.S.-headquartered Eli Lilly and Johnson & Johnson — who have all vowed over recent months to ramp up their U.S. investment amid U.S. President Donald Trump's demands to reshore domestic manufacturing. The industry is awaiting further clarity on the Trump administration's pharma tariffs, with the final outcome of a Section 232 investigation into the sector due at the end of this month. An effort to rebalance U.S. drug prices with those paid by other countries is also underway. Trump earlier this month suggested that the industry could face levies of up to 200%, with a brief 12-18 month grace period to allow firms to relocate manufacturing stateside. However, many firms and analysts have dubbed the time frame as insufficient. "Typically for most medicines it's a three to four year horizon. We're working very hard to accelerate that as fast as we can and demonstrate we're making the investments we have planned," Novartis CEO Vas Narasimhan said last week during an earnings call, adding that he hoped the administration would make allowances.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store